Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All acetaminophen studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAcetaminophenAcetaminophen (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

How Much has COVID-19 Contributed to Increase the Worldwide Consumption of Paracetamol and Ibuprofen? Evidence From an Infodemiological Analysis

Mattiuzzi et al., Hospital Pharmacy, doi:10.1177/00185787221125721
Sep 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
2nd treatment shown to increase risk in November 2020
 
*, now with p = 0.00000029 from 27 studies, but still recommended in 64 countries.
* From meta analysis with ≥3 studies.
5,000+ studies for 104 treatments. c19early.org
Infodemiological analysis showing a significant worldwide increase in Google searches for paracetamol (54%) and ibuprofen (24%) during the COVID-19 pandemic compared to pre-pandemic levels, suggesting dramatically increased consumption.
Paracetamol is also known as acetaminophen, Tylenol, Panadol, Calpol, Tempra, Calprofen, Doliprane, Efferalgan, Grippostad C, Dolo, Acamol, Fevadol, Crocin, and Perfalgan.
Study covers acetaminophen and ibuprofen.
Mattiuzzi et al., 24 Sep 2022, peer-reviewed, 2 authors, study period March 2020 - July 2022. Contact: giuseppe.lippi@univr.it.
This PaperAcetaminophenAll
Abstract: 1125721 letter2022 HPXXXX10.1177/00185787221125721Hospital PharmacyMattiuzzi and Lippi Letter to the Editor How Much has COVID-19 Contributed to Increase the Worldwide Consumption of Paracetamol and Ibuprofen? Evidence From an Infodemiological Analysis Hospital Pharmacy 2023, Vol. 58(1) 7­–8 © The Author(s) 2022 Article reuse guidelines: sagepub.com/journals-permissions https://doi.org/10.1177/00185787221125721 DOI: 10.1177/00185787221125721 journals.sagepub.com/home/hpx Camilla Mattiuzzi1 and Giuseppe Lippi2 To the Editor, Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for treating viral infections, and their usage is also widespread in patients with coronavirus disease 2019 (COVID-19), especially in those with milder illness.1 Several lines of evidence demonstrates, in fact, that early anti-inflammatory therapy may prevent endothelia inflammation and the consequent risk of developing immunethrombosis, which would be associated with a substantially enhanced prescription of these drugs, potentially leading to medication shortage.2 We have hence planned an infodemiological analysis to establish whether the consumption of some representative NSAIDs has increased all around the world after the spread of COVID-19. We accessed Google Trends (Google Inc. Mountain View, CA, US) using the key words “paracetamol” (or acetaminophen) and “ibuprofen,” setting the geographical location to “worldwide,” and limiting our search to the past 5 years (ie, between July 2017 and July 2022). The weekly Google Trends score for both terms “paracetamol” and “ibuprofen,” thus mirroring their Web worldwide popularity, was divided into 2 different periods, that is, “pre-COVID-19” (from July 2017 to February 2020) and COVID-19 (from March 2020 to July 2022).3 The relative volumes of Google searches for both terms over time was then analyzed with Spearman’s correlation and compared between the COVID-19 and preCOVID-19 periods with Mann-Whitney test (Analyse-it Software Ltd, Leeds, UK). The main results of this worldwide infodemiological analysis are summarized in Figure 1. A highly significant Spearman’s correlation was found between time and weekly Google Trends score of both paracetamol (r = .89; 95% CI, 0.87-0.92; P < .001) and ibuprofen (r = .78; 95% CI, 0.730.83; P < .001). Compared to the pre-COVID-19 period, the median (and interquartile range; IQR) weekly Google Trends score significantly increased by 54% for paracetamol (43 with IQR 34-47 vs 28 with IQR 26-31; P < .001) and by 24% for ibuprofen (31 with IQR 27-37 vs 25 with IQR 23-27; P < .001) during the COVID-19 pandemic, with Google Figure 1. Worldwide weekly Google Trends score for “paracetamol” and “ibuprofen” before and after the emergence of the coronavirus disease 2019 (COVID-19) pandemic. Trends score of paracetamol remaining constantly higher than that of Ibuprofen (P < .001). In conclusion, the results of this infodemiological analysis confirm that NSAIDs consumption may have dramatically increased on a worldwide scale after the emergence of the COVID-19 pandemic, thus needing strengthened efforts for monitoring appropriate prescription and limiting side effects, as well as for preventing potential drugs shortage. 1 Service of Clinical Governance, Provincial Agency for Social and Sanitary Services (APSS), Trento, Italy 2 University of Verona, Verona, Italy Corresponding Author: Giuseppe Lippi, Section of Clinical Biochemistry, University Hospital of Verona,..
{ 'indexed': {'date-parts': [[2024, 5, 27]], 'date-time': '2024-05-27T22:34:45Z', 'timestamp': 1716849285675}, 'reference-count': 3, 'publisher': 'SAGE Publications', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2022, 9, 24]], 'date-time': '2022-09-24T00:00:00Z', 'timestamp': 1663977600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'http://journals.sagepub.com/page/policies/text-and-data-mining-license'}], 'content-domain': {'domain': ['journals.sagepub.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023, 2]]}, 'DOI': '10.1177/00185787221125721', 'type': 'journal-article', 'created': {'date-parts': [[2022, 9, 24]], 'date-time': '2022-09-24T11:49:18Z', 'timestamp': 1664020158000}, 'page': '7-8', 'update-policy': 'http://dx.doi.org/10.1177/sage-journals-update-policy', 'source': 'Crossref', 'is-referenced-by-count': 6, 'title': 'How Much has COVID-19 Contributed to Increase the Worldwide Consumption of Paracetamol and ' 'Ibuprofen? Evidence From an Infodemiological Analysis', 'prefix': '10.1177', 'volume': '58', 'author': [ { 'given': 'Camilla', 'family': 'Mattiuzzi', 'sequence': 'first', 'affiliation': [ { 'name': 'Service of Clinical Governance, Provincial Agency for Social and ' 'Sanitary Services (APSS), Trento, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0001-9523-9054', 'authenticated-orcid': False, 'given': 'Giuseppe', 'family': 'Lippi', 'sequence': 'additional', 'affiliation': [{'name': 'University of Verona, Verona, Italy'}]}], 'member': '179', 'published-online': {'date-parts': [[2022, 9, 24]]}, 'reference': [ { 'key': 'bibr1-00185787221125721', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s40264-021-01089-5'}, { 'key': 'bibr2-00185787221125721', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/00185787211046861'}, { 'key': 'bibr3-00185787221125721', 'first-page': '157', 'volume': '91', 'author': 'Cucinotta D', 'year': '2020', 'journal-title': 'Acta Biomed'}], 'container-title': 'Hospital Pharmacy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'http://journals.sagepub.com/doi/pdf/10.1177/00185787221125721', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://journals.sagepub.com/doi/full-xml/10.1177/00185787221125721', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://journals.sagepub.com/doi/pdf/10.1177/00185787221125721', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 2, 14]], 'date-time': '2023-02-14T07:12:22Z', 'timestamp': 1676358742000}, 'score': 1, 'resource': {'primary': {'URL': 'http://journals.sagepub.com/doi/10.1177/00185787221125721'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 9, 24]]}, 'references-count': 3, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2023, 2]]}}, 'alternative-id': ['10.1177/00185787221125721'], 'URL': 'http://dx.doi.org/10.1177/00185787221125721', 'relation': {}, 'ISSN': ['0018-5787', '1945-1253'], 'subject': [], 'container-title-short': 'Hosp Pharm', 'published': {'date-parts': [[2022, 9, 24]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit